martes, 14 de noviembre de 2017

Legionella pneumophila Serogroup 1 in the Water Facilities of a Tertiary Healthcare Center, India - Volume 23, Number 11—November 2017 - Emerging Infectious Disease journal - CDC

Legionella pneumophila Serogroup 1 in the Water Facilities of a Tertiary Healthcare Center, India - Volume 23, Number 11—November 2017 - Emerging Infectious Disease journal - CDC



Volume 23, Number 11—November 2017

Research Letter

Legionella pneumophila Serogroup 1 in the Water Facilities of a Tertiary Healthcare Center, India

Rama ChaudhryComments to Author , K. Sreenath, Valavane Arvind, E.V. Vinayaraj, and Sagar Tanu
Author affiliations: All India Institute of Medical Sciences, New Delhi, India

Abstract

Proactive environmental surveillance for Legionella pneumophila in hospitals that treat immunocompromised patients is a useful strategy for preventing nosocomial Legionnaires’ disease. We report the presence of L. pneumophila serogroup 1 in 15.2% of the water systems of our tertiary healthcare center, which should prompt health officials to formulate mitigation policies.
Legionella pneumophila, the causative agent of Legionnaires’ disease (LD), is a bacterium omnipresent in aquatic environments and increasingly recognized as a major cause of community- and hospital-acquired pneumonia. L. pneumophila serogroup 1 (Lp1), the dominant serogroup, accounts for ≈84% of human infections worldwide (1,2). Hospital-acquired LD has been reported globally, and routine use of environmental cultures is recommended as a useful strategy to prevent infections (3). Although proactive environmental surveillance of Legionella and regular treatment of cooling tower installations are recommended in many countries, these practices are not routine in India, and limited studies have been conducted in this country for monitoring Legionella contamination in hospital water systems (4). We conducted a study to detect L. pneumophila and to identify Lp1 in the water systems of a tertiary healthcare center in northern India that has organ transplantation and cancer treatment facilities.
We collected 79 water samples (41 potable, 38 nonpotable) from the hospital and general areas of the healthcare center during an 18-month period (May 2015–October 2016). Of 79 samples, 27 were collected from patient areas (wards, intensive care units, outpatient departments, emergency units, and procedure rooms); 14 from residential areas; 15 from cooling towers; and 23 from other buildings (e.g., laboratory divisions, teaching departments, library, and recreational zones). We followed guidelines issued by the US Centers for Disease Control and Prevention regarding isolation of Legionella (5). In brief, we concentrated 500 mL of water samples and decontaminated 1 part by using heat treatment (in water bath at 50°C for 30 min) and 1 part by acid (in equal volume of HCl-KCl acid buffer [pH 2.2]). We then inoculated 0.1-mL samples onto buffered charcoal yeast extract agar (Becton Dickinson, Sparks, MD, USA) supplemented with glycine, vancomycin, polymyxin B, and cycloheximide (Oxoid, Basingstoke, UK). We presumptively identified colonies growing only on buffered charcoal yeast extract but not on blood agar as Legionella species and confirmed the presence of L. pneumophila by amplification of a 375-bp region of the mip gene using previously published primers (6). We identified Lp1 by using a real-time PCR (rPCR) assay targeting the wzm gene (7). We used genomic DNA isolated from L. pneumophila strain Philadelphia (ATCC 33152) for standardization of PCR and rPCR and L. pneumophila strain Knoxville (ATCC 33153) for standardization of culture.
We identified Legionella spp. in 21 (26.6%) of 79 water samples (10 potable and 11 nonpotable) by culture. We obtained a collection of 28 isolates from the 79 samples and identified all of them as L. pneumophila by PCR. Among these 28 isolates, 18 (64.3%) tested positive for Lp1 by rPCR, indicating the presence of this pathogenic serogroup in 12 (15.2%) of the 79 water samples (5 potable and 7 nonpotable).
We repeatedly isolated L. pneumophila (˃4 times) from 2 high-risk sites: a drinking water unit and a cooling tower situated inside the hospital campus. Four water samples collected from patient areas tested positive for L. pneumophila, posing a risk for nosocomial infection. We isolated L. pneumophilafrom water bodies with temperatures ranging from 12°C to 57°C but most frequently (11 times) from those with temperatures of 25°C–50°C. We summarized the isolation of L. pneumophila with respect to type of water sample, sampling site, and temperature (Table).
We demonstrated the presence of Lp1 in the hospital water systems, indicating that LD might be a common cause of pneumonia in this setting. Previously published reports have documented infections attributable to L. pneumophila in patients with community-acquired pneumonia; however, the prevalence of nosocomial legionellosis in India remains unknown (4,8,9).
On the basis of our findings, we initiated infection-control measures and created awareness to formulate Legionella risk management in this hospital. We ensured that physicians were cognizant of possible Legionella colonization in the hospital water supply and advised them to recommend Legionelladiagnostic testing for patients with suspected nosocomial pneumonia. Underdiagnosed nosocomial legionellosis might become evident as the awareness of clinicians increases and as specialized laboratory testing for the pathogen becomes easily available.
Eradication of Legionella from aquatic bodies is a herculean task. Numerous systemic disinfection measures are available, such as super heat and flush, copper-silver ionization, chlorine dioxide, and point-of-use filters, but no method is ideal for complete eradication of the contagion (10). We advised the hospital’s engineers and healthcare facility managers to install point-of-use filters to the drinking water taps in areas where Legionella was isolated. Repeat sampling of 2 sites that had once tested positive for Legionella showed that they were culture-negative for the pathogen 6 six months after installation of the filters. However, to evaluate the efficacy of any disinfection method, validation and monitoring over a prolonged period is required.
Our findings might be an important sentinel of an underestimated threat and could be useful for health officials in India to set standards for LD surveillance and control in hospitals. Although we did not perform sequence-based typing in this study, examination of Legionella from natural sources and advances in molecular typing might help clarify the distribution and natural history of LD in this region.
Dr. Chaudhry is professor of microbiology at All India Institute of Medical Sciences, New Delhi, India, and American Society for Microbiology international ambassador to India. Her research focuses on atypical pneumonia, vectorborne diseases, anaerobic infections, probiotics, and metagenomics.

Acknowledgment

The authors acknowledge Arti Kapil, Bijay Ranjan Mirdha, Benu Dhawan, and Urvashi B. Singh for their valuable suggestions and inputs. We also thank Mohanlal Sharma, Puran Ram, and Pramod Kumar for their technical support.

References

  1. Fields BSBenson RFBesser RELegionella and Legionnaires’ disease: 25 years of investigation. Clin Microbiol Rev2002;15:50626DOIPubMed
  2. Mercante JWWinchell JMCurrent and emerging Legionella diagnostics for laboratory and outbreak investigations. Clin Microbiol Rev2015;28:95133DOIPubMed
  3. Sabria MYu VLHospital-acquired legionellosis: solutions for a preventable infection. Lancet Infect Dis2002;2:36873DOIPubMed
  4. Anbumani SGururajkumar AChaudhury AIsolation of Legionella pneumophila from clinical & environmental sources in a tertiary care hospital.Indian J Med Res2010;131:7614.PubMed
  5. Centers for Disease Control and Prevention. Procedures for the recovery of Legionella from the environment. Atlanta: US Department of Health and Human Services, Public Health Service; 2005. p. 1–13.
  6. Welti MJaton KAltwegg MSahli RWenger ABille JDevelopment of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions. Diagn Microbiol Infect Dis2003;45:8595DOIPubMed
  7. Benitez AJWinchell JMClinical application of a multiplex real-time PCR assay for simultaneous detection of Legionella species, Legionella pneumophila, and Legionella pneumophila serogroup 1. J Clin Microbiol2013;51:34851DOIPubMed
  8. Chaudhry RValavane AMohan ADey ABLegionella pneumophila infection associated with renal failure causing fatality in a known case of sarcoidosis. Indian J Med Microbiol2014;32:3247DOIPubMed
  9. Angrup AChaudhry RSharma SValavane APassi KPadmaja Ket al. Application of real-time quantitative polymerase chain reaction assay to detect Legionella pneumophila in patients of community-acquired pneumonia in a tertiary care hospital. Indian J Med Microbiol2016;34:53943DOIPubMed
  10. Lin YEStout JEYu VLControlling Legionella in hospital drinking water: an evidence-based review of disinfection methods. Infect Control Hosp Epidemiol2011;32:16673DOIPubMed

Table

Cite This Article

DOI: 10.3201/eid2311.171071

No hay comentarios:

Publicar un comentario